Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-26-000002

CHIEF EXECUTIVE OFFICER sold 7,098 shares at $93.33 ($662,422)

  • CHIEF EXECUTIVE OFFICER acquired 12,797 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peetz Christopher CHIEF EXECUTIVE OFFICER 2026-01-21 Option exercise +12,797 170,831 D: show line 1 in the form
Peetz Christopher CHIEF EXECUTIVE OFFICER 2026-01-22 Sale −7,098 $93.33 $662,422 163,733 D: show line 2 in the form
Open-market sales · 7,098 sh · avg $93.33 · $662,422

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Peetz Christopher CHIEF EXECUTIVE OFFICER 2026-01-21 Option exercise · Restricted Stock Units −12,797 25,593 D: show line 3 in the form
Loading xslF345X05/form4-01232026_050101.xml…